October 28, 2010 8:56 AM | 30 seconds read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Thermo Fisher Scientific, Inc. (NYSE: TMO) reported 3Q2010 revenues/EPS of $2.68b/$0.90 that “beat our $2.61b/$0.81 estimates and consensus of $2.59b/$0.83,” Goldman Sachs reports.Organic revenue growth of 4% exceeded expectations by 100bps and combined with solid margins to yield a clean beat for the quarter.“We are revising our 2010-2012 estimates to $3.52/$3.96/$4.28 from $3.45/$3.86/$4.23 to reflect the strength in the Analytical Technologies division, higher FY2010 guidance, and updated F/X assumptions,” Goldman Sachs writes. “Our revised 12-month price target of $53 (previously $51) is based on our updated FY2011 estimates and unchanged multiples (P/E, EV/EBITDA).”Thermo Fisher Scientific currently trades at $51.31.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.